AbGenomics
A biopharmaceutical company developing treatments and prevention for inflammatory, autoimmune disease and cancer
2
Funding Rounds
$26.5m
Money raised
Overview
A biopharmaceutical company developing treatments and prevention for inflammatory, autoimmune disease and cancer
- Website:
Funding
Funding series
Funding Series Analysis
The company AbGenomics has raised a total of $26.45m in funding over 2 rounds.
Key Insights:
- AbGenomics funding round, July 2013: $9.6m
- AbGenomics Series A round: $16.85m
AbGenomics funding round, July 2013
$9.6m
AbGenomics Series A round
$16.85m
Industries
AbGenomics is active in the following industries: